Axcella Price to Earning

AXLA
 Stock
  

USD 0.84  0.07  7.69%   

Axcella Health fundamentals help investors to digest information that contributes to Axcella Health's financial success or failures. It also enables traders to predict the movement of Axcella Stock. The fundamental analysis module provides a way to measure Axcella Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axcella Health stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Axcella Price to Earning Analysis

Axcella Health's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
More About Price to Earning | All Equity Analysis

Current Axcella Health Price to Earning

    
  (1.10) X  
Most of Axcella Health's fundamental indicators, such as Price to Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axcella Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Compare to competition

Based on the latest financial disclosure, the price to earning indicator of Axcella Health is roughly -1.0973 times. This is 104.25% lower than that of the Biotechnology sector and 122.26% lower than that of the Health Care industry. The price to earning for all United States stocks is 103.82% higher than that of the company.

Axcella Price to Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axcella Health's direct or indirect competition against its Price to Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axcella Health could also be used in its relative valuation, which is a method of valuing Axcella Health by comparing valuation metrics of similar companies.
Axcella Health is currently under evaluation in price to earning category among related companies.

Axcella Fundamentals

About Axcella Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Axcella Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axcella Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axcella Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Axcella Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Axcella Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Pair Trading with Axcella Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axcella Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axcella Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Axcella Health

+0.71BEAMBeam TherapeuticsInc Normal TradingPairCorr

Moving against Axcella Health

-0.81JPMJPMorgan Chase Fiscal Year End 13th of January 2023 PairCorr
-0.78MRNAModerna Potential GrowthPairCorr
The ability to find closely correlated positions to Axcella Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axcella Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axcella Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axcella Health to buy it.
The correlation of Axcella Health is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axcella Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axcella Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axcella Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Axcella Health Piotroski F Score and Axcella Health Altman Z Score analysis. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for analysis

When running Axcella Health price analysis, check to measure Axcella Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axcella Health is operating at the current time. Most of Axcella Health's value examination focuses on studying past and present price action to predict the probability of Axcella Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Axcella Health's price. Additionally, you may evaluate how the addition of Axcella Health to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Axcella Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axcella Health. If investors know Axcella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axcella Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
67.6 M
Return On Assets
(0.92) 
Return On Equity
(5.43) 
The market value of Axcella Health is measured differently than its book value, which is the value of Axcella that is recorded on the company's balance sheet. Investors also form their own opinion of Axcella Health's value that differs from its market value or its book value, called intrinsic value, which is Axcella Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axcella Health's market value can be influenced by many factors that don't directly affect Axcella Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axcella Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Axcella Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axcella Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.